High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer
Open Access
- 1 August 2019
- journal article
- clinical trial
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 20 (8) , 2319-2326
Abstract
Background: KRAS, NRAS, and BRAF gene mutations are the most clinically relevant and frequently reported incolorectal cancer (CRC). Although data on these genes are frequently reported in several counties, data specific to thesegenes among Thai population are scarce. The aim of this study was to investigate and identify molecular alterationsassociated with colon cancer in Thai population, and to determine the impact of these genetic aberrations on clinicaloutcome. Methods: DNA from 108 archived formalin-fixed, paraffin-embedded (FFPE) tissue samples that histologicallyconfirmed adenocarcinoma of stage II-III colon cancer between 2010 and 2012 at Siriraj Hospital (Bangkok, Thailand)were extracted. Gene mutational analysis was performed by next-generation sequencing (NGS) using an OncomineSolid Tumor DNA kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Results: A total of 22 somatic genemutations were detected. The mutation frequency observed in KRAS, NRAS, BRAF, PIK3CA, and FBXW7 mutationswas 47.2%, 1.9%, 1.9%, 12%, and 14.8%, respectively. KRAS mutation codon 12, 13, 59, 61, 117, and 146 mutationswere identified in 29.6%, 8.3%, 1.8%, 0.9%, 0.0%, and 8.3%, respectively. KRAS Exon 4 had better DFS comparedwith Exon 2 and 3. Conclusions: This study is the first to comprehensively report hotspot mutations using NGS in Thaicolon cancer patients. The most commonly identified gene mutation frequencies among Thai patients (KRAS, NRAS,BRAF, TP53, and PIK3CA) were similar to the gene mutation frequencies reported in Western population, except forsubgroup of KRAS codon 146 and FBXW7 mutations that had a slightly higher frequency.Keywords
This publication has 61 references indexed in Scilit:
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and SurvivalPLOS ONE, 2013
- Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility studyClinical and Experimental Gastroenterology, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese populationClinica Chimica Acta, 2012
- Molecular profile and copy number analysis of sporadic colorectal cancer in TaiwanJournal of Biomedical Science, 2011
- Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese populationInternational Journal of Colorectal Disease, 2011
- Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patientsWorld Journal of Gastroenterology, 2011
- NRAS Mutations Are Rare in Colorectal CancerDiagnostic Molecular Pathology, 2010
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal CancerPLOS ONE, 2009